US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 21.470
  • +0.290+1.37%
Close Nov 25 16:00 ET
  • 21.550
  • +0.080+0.37%
Pre 08:31 ET
5.08BMarket Cap79.52P/E (TTM)

ADMA Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
108.83%25.03M
853.36%45.65M
84.94%-2.22M
114.79%8.8M
338.47%17.6M
190.22%11.99M
52.78%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
Net income from continuing operations
1,299.42%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Operating gains losses
-91.40%8K
--1K
27.78%23K
271.37%26.36M
6,168.94%26.25M
1,511.79%93K
--0
-99.73%18K
3,111.31%7.1M
197.93%418.65K
Depreciation and amortization
-7.27%1.94M
-2.43%2.05M
3.98%2.11M
17.14%8.33M
8.91%2.11M
12.35%2.09M
21.67%2.1M
27.84%2.03M
29.42%7.11M
27.55%1.94M
Other non cash items
-87.13%216K
-88.28%192K
-84.85%217K
19.59%6.29M
7.47%1.54M
-12.77%1.68M
21.14%1.64M
160.77%1.43M
199.71%5.26M
206.66%1.43M
Change In working capital
-520.20%-16.22M
267.58%8.48M
-95.73%-24.52M
44.64%-10.12M
99,630.52%3.6M
210.63%3.86M
-51.80%-5.06M
-9.33%-12.53M
64.62%-18.29M
99.98%-3.62K
-Change in receivables
-469.98%-20.03M
290.99%19.51M
-101.58%-22.2M
-191.16%-11.92M
-27.78%3.9M
368.16%5.41M
-251.41%-10.21M
-473.67%-11.01M
185.22%13.07M
165.95%5.4M
-Change in inventory
699.48%8.01M
-194.24%-2.08M
-584.54%-4.83M
75.03%-9.63M
-2,571.53%-9.79M
92.07%-1.34M
131.82%2.21M
95.11%-705K
10.73%-38.56M
96.54%-366.46K
-Change in prepaid assets
-5,961.11%-4.36M
59.88%-869K
-39.20%611K
232.65%841K
919.25%2.07M
84.40%-72K
-264.94%-2.17M
361.82%1.01M
79.34%-634K
-63.53%203.48K
-Change in payables and accrued expense
1,041.60%1.43M
-249.88%-7.82M
174.92%1.22M
36.42%11.37M
249.99%7.65M
-99.22%125K
316.27%5.22M
-1,711.76%-1.63M
-14.06%8.33M
-150.28%-5.1M
-Change in other current liabilities
-371.75%-1.27M
-145.71%-258K
462.03%677K
-57.57%-791K
-68.39%-230K
-143.61%-269K
27.05%-105K
-68.37%-187K
-329.22%-502K
-222.55%-136.59K
Cash from discontinued investing activities
Operating cash flow
108.83%25.03M
853.36%45.65M
84.94%-2.22M
114.79%8.8M
338.47%17.6M
190.22%11.99M
52.78%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
Investing cash flow
Cash flow from continuing investing activities
-45.05%-1.1M
-171.22%-2.37M
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.61%-757K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
Net PPE purchase and sale
-39.50%-1.06M
-136.93%-2.07M
-20.67%-2.35M
65.70%-4.77M
68.07%-1.2M
77.61%-757K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
Net intangibles purchase and sale
---42K
---299K
---15K
---210K
---210K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
-45.05%-1.1M
-171.22%-2.37M
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.61%-757K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
Financing cash flow
Cash flow from continuing financing activities
-6,221.88%-25.47M
-250.83%-362K
-122.62%-1.45M
-135.82%-38.99M
-162.15%-39M
149.30%416K
175.23%240K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
Net issuance payments of debt
---30M
--0
--0
-145.64%-23.6M
-270,401.20%-23.59M
--0
34.02%-6K
-100.02%-10K
152,200.00%51.71M
-2.66%-8.72K
Net common stock issuance
----
----
----
--0
----
----
----
----
-46.64%64.65M
----
Proceeds from stock option exercised by employees
812.02%5.69M
-29.87%331K
--1.03M
530.86%1.1M
-95.43%8K
--624K
--472K
--0
--175K
--175K
Net other financing activities
-456.73%-1.16M
-206.64%-693K
-286.88%-2.48M
-114.68%-16.49M
-645.63%-15.42M
75.08%-208K
27.08%-226K
85.68%-640K
-12,290.32%-7.68M
-514,271.89%-2.07M
Cash from discontinued financing activities
Financing cash flow
-6,221.88%-25.47M
-250.83%-362K
-122.62%-1.45M
-135.82%-38.99M
-162.15%-39M
149.30%416K
175.23%240K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
Net cash flow
Beginning cash position
41.16%88.24M
-34.51%45.33M
-40.65%51.35M
69.36%86.52M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
-8.64%51.09M
1.44%34.91M
Current changes in cash
-113.20%-1.54M
741.44%42.92M
65.20%-6.03M
-199.26%-35.17M
-144.18%-22.81M
166.50%11.64M
60.85%-6.69M
-194.04%-17.32M
833.30%35.43M
209.48%51.62M
End cash Position
16.92%86.71M
41.16%88.24M
-34.51%45.33M
-40.65%51.35M
-40.65%51.35M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
69.36%86.52M
Free cash flow
113.13%23.93M
724.46%43.28M
72.52%-4.58M
105.20%3.82M
245.50%16.19M
167.37%11.23M
58.67%-6.93M
42.24%-16.67M
41.68%-73.42M
70.04%-11.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 108.83%25.03M853.36%45.65M84.94%-2.22M114.79%8.8M338.47%17.6M190.22%11.99M52.78%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M
Net income from continuing operations 1,299.42%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Operating gains losses -91.40%8K--1K27.78%23K271.37%26.36M6,168.94%26.25M1,511.79%93K--0-99.73%18K3,111.31%7.1M197.93%418.65K
Depreciation and amortization -7.27%1.94M-2.43%2.05M3.98%2.11M17.14%8.33M8.91%2.11M12.35%2.09M21.67%2.1M27.84%2.03M29.42%7.11M27.55%1.94M
Other non cash items -87.13%216K-88.28%192K-84.85%217K19.59%6.29M7.47%1.54M-12.77%1.68M21.14%1.64M160.77%1.43M199.71%5.26M206.66%1.43M
Change In working capital -520.20%-16.22M267.58%8.48M-95.73%-24.52M44.64%-10.12M99,630.52%3.6M210.63%3.86M-51.80%-5.06M-9.33%-12.53M64.62%-18.29M99.98%-3.62K
-Change in receivables -469.98%-20.03M290.99%19.51M-101.58%-22.2M-191.16%-11.92M-27.78%3.9M368.16%5.41M-251.41%-10.21M-473.67%-11.01M185.22%13.07M165.95%5.4M
-Change in inventory 699.48%8.01M-194.24%-2.08M-584.54%-4.83M75.03%-9.63M-2,571.53%-9.79M92.07%-1.34M131.82%2.21M95.11%-705K10.73%-38.56M96.54%-366.46K
-Change in prepaid assets -5,961.11%-4.36M59.88%-869K-39.20%611K232.65%841K919.25%2.07M84.40%-72K-264.94%-2.17M361.82%1.01M79.34%-634K-63.53%203.48K
-Change in payables and accrued expense 1,041.60%1.43M-249.88%-7.82M174.92%1.22M36.42%11.37M249.99%7.65M-99.22%125K316.27%5.22M-1,711.76%-1.63M-14.06%8.33M-150.28%-5.1M
-Change in other current liabilities -371.75%-1.27M-145.71%-258K462.03%677K-57.57%-791K-68.39%-230K-143.61%-269K27.05%-105K-68.37%-187K-329.22%-502K-222.55%-136.59K
Cash from discontinued investing activities
Operating cash flow 108.83%25.03M853.36%45.65M84.94%-2.22M114.79%8.8M338.47%17.6M190.22%11.99M52.78%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M
Investing cash flow
Cash flow from continuing investing activities -45.05%-1.1M-171.22%-2.37M-21.44%-2.36M64.19%-4.98M62.46%-1.41M77.61%-757K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M
Net PPE purchase and sale -39.50%-1.06M-136.93%-2.07M-20.67%-2.35M65.70%-4.77M68.07%-1.2M77.61%-757K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M
Net intangibles purchase and sale ---42K---299K---15K---210K---210K--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow -45.05%-1.1M-171.22%-2.37M-21.44%-2.36M64.19%-4.98M62.46%-1.41M77.61%-757K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M
Financing cash flow
Cash flow from continuing financing activities -6,221.88%-25.47M-250.83%-362K-122.62%-1.45M-135.82%-38.99M-162.15%-39M149.30%416K175.23%240K-101.38%-650K-10.08%108.85M16.58%62.74M
Net issuance payments of debt ---30M--0--0-145.64%-23.6M-270,401.20%-23.59M--034.02%-6K-100.02%-10K152,200.00%51.71M-2.66%-8.72K
Net common stock issuance --------------0-----------------46.64%64.65M----
Proceeds from stock option exercised by employees 812.02%5.69M-29.87%331K--1.03M530.86%1.1M-95.43%8K--624K--472K--0--175K--175K
Net other financing activities -456.73%-1.16M-206.64%-693K-286.88%-2.48M-114.68%-16.49M-645.63%-15.42M75.08%-208K27.08%-226K85.68%-640K-12,290.32%-7.68M-514,271.89%-2.07M
Cash from discontinued financing activities
Financing cash flow -6,221.88%-25.47M-250.83%-362K-122.62%-1.45M-135.82%-38.99M-162.15%-39M149.30%416K175.23%240K-101.38%-650K-10.08%108.85M16.58%62.74M
Net cash flow
Beginning cash position 41.16%88.24M-34.51%45.33M-40.65%51.35M69.36%86.52M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M-8.64%51.09M1.44%34.91M
Current changes in cash -113.20%-1.54M741.44%42.92M65.20%-6.03M-199.26%-35.17M-144.18%-22.81M166.50%11.64M60.85%-6.69M-194.04%-17.32M833.30%35.43M209.48%51.62M
End cash Position 16.92%86.71M41.16%88.24M-34.51%45.33M-40.65%51.35M-40.65%51.35M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M69.36%86.52M
Free cash flow 113.13%23.93M724.46%43.28M72.52%-4.58M105.20%3.82M245.50%16.19M167.37%11.23M58.67%-6.93M42.24%-16.67M41.68%-73.42M70.04%-11.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data